Lincoln Pharmaceuticals Ltd's market cap is currently ₹14.91B. The company's EPS TTM is ₹48.247; its P/E ratio is 15.43; and it has a dividend yield of 0.26%. Lincoln Pharmaceuticals Ltd is scheduled to report earnings on February 6, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Income Statement
Total Revenue	₹ 5.81B	₹ 5.10B	₹ 4.68B	₹ 4.15B	₹ 3.77B
Gross Profit	₹ 3.01B	₹ 2.69B	₹ 2.48B	₹ 2.16B	₹ 1.93B
Operating Income	₹ 1.91B	₹ 805.47M	₹ 876.98M	₹ 798.01M	₹ 583.39M
EBITDA	₹ 1.34B	₹ 1.12B	₹ 1.05B	₹ 928.43M	₹ 765.76M
Net Income	₹ 933.05M	₹ 728.99M	₹ 693.55M	₹ 622.50M	₹ 514.39M
Balance Sheet
Cash & Short-Term Investments	₹ 1.45B	₹ 1.26B	₹ 1.15B	₹ 921.10M	₹ 235.58M
Total Assets	₹ 7.00B	₹ 5.87B	₹ 5.34B	₹ 4.59B	₹ 3.66B
Total Debt	₹ 10.67M	₹ 19.97M	₹ 20.44M	₹ 5.20M	₹ 336.09M
Net Debt	₹ -46.80M	₹ -30.55M	₹ -48.90M	₹ -109.19M	₹ 281.52M
Total Liabilities	₹ 1.07B	₹ 849.46M	₹ 1.01B	₹ 836.72M	₹ 962.85M
Stockholders' Equity	₹ 5.93B	₹ 5.02B	₹ 4.33B	₹ 3.75B	₹ 2.69B
Cash Flow
Free Cash Flow	₹ 236.04M	₹ 249.80M	₹ 306.07M	₹ 605.20M	₹ 677.24M
Operating Cash Flow	₹ 632.17M	₹ 392.62M	₹ 761.32M	₹ 692.70M	₹ 754.15M
Investing Cash Flow	₹ -573.42M	₹ -366.43M	₹ -780.80M	₹ -642.27M	₹ -308.83M
Financing Cash Flow	₹ -51.80M	₹ -45.01M	₹ -25.56M	₹ -57.46M	₹ -377.59M

Currency in INR

Lincoln Pharmaceuticals Ltd Earnings and Revenue History

Income Statement >

Lincoln Pharmaceuticals Ltd Debt to Assets

Balance Sheet >

Lincoln Pharmaceuticals Ltd Cash Flow

Cash Flow >

Lincoln Pharmaceuticals Ltd Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing